ESTHER ANYAORAH: Open Payments
NPI 1316435860 · RICHMOND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 51 payments from 8 companies in 2025. Trend: 2023 $2,303 · 2024 $1,491 · 2025 $1,612
Food & beverage: $1,612
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $433 |
| Alkermes, Inc. | 13 | $416 |
| Janssen Pharmaceuticals, Inc | 8 | $298 |
| Otsuka America Pharmaceutical, Inc. | 10 | $263 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: INVEGA SUSTENNA, UZEDY, ARISTADA, AUSTEDO XR, LYBALVI, ABILIFY MAINTENA, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
